2024 Global Peptide Drug Sales Ranking Released
Publish Time:
2025-07-22
Recently released data shows that the global peptide drug market in 2024 is experiencing significant growth, primarily driven by GLP-1 receptor agonists. CongenPharma, a specialized supplier in peptide synthesis, continuously provides crucial raw materials and technical support for global peptide drug R&D.
Market Leader
Novo Nordisk's flagship product, Semaglutide (brand names: Wegovy/Ozempic), secured the top spot with a record-breaking $29.27 billion in sales. This figure surpasses the combined sales of the products ranked 2nd to 4th, which include:
• Tirzepatide (Eli Lilly, $16.47 billion)
• Dulaglutide (Eli Lilly, $5.25 billion)
• Insulin Glargine (Sanofi, $3.77 billion)
Market Tiers
The market shows four distinct tiers:
Tier 1 (> $10 billion): Semaglutide, Tirzepatide
Tier 2 ($5-10 billion): Dulaglutide
Tier 3 ($1-5 billion): 12 products
Tier 4 ($0.1-1 billion): 19 products
Highlights in Specific Areas
• Oncology: Amgen's Carfilzomib reached $1.5 billion in sales
• Hematology: Amgen's Romiplostim achieved $1.46 billion in sales
• Combination Drugs: Aspart insulin/Degludec insulin ($715 million), Degludec insulin/Liraglutide ($653 million) showed outstanding performance
Technological Trends
CongenPharma's R&D director points out: "Three key technological features characterized the peptide drug market in 2024:
GLP-1 drugs lead market growth
Breakthrough in long-chain peptide synthesis technology
Surging demand for novel delivery systems
As a professional peptide synthesis manufacturer, CongenPharma has successfully developed:
• High-difficulty long-chain peptide synthesis processes
• High-purity GLP-1 analog intermediates
• Innovative peptide conjugation technology
About CongenPharma
CongenPharma is a professional supplier of peptide raw materials and technical services, focusing on:
✓ Peptide raw material production
✓ Custom peptide synthesis services
✓ Peptide process development and optimization
✓ Analytical method development and validation
Relevant Information
undefined
